Cargando…
Opioid Receptor Activation Impairs Hypoglycemic Counterregulation in Humans
Although intensive glycemic control improves outcomes in type 1 diabetes mellitus (T1DM), iatrogenic hypoglycemia limits its attainment. Recurrent and/or antecedent hypoglycemia causes blunting of protective counterregulatory responses, known as hypoglycemia-associated autonomic failure (HAAF). To d...
Autores principales: | Carey, Michelle, Gospin, Rebekah, Goyal, Akankasha, Tomuta, Nora, Sandu, Oana, Mbanya, Armand, Lontchi-Yimagou, Eric, Hulkower, Raphael, Shamoon, Harry, Gabriely, Ilan, Hawkins, Meredith |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5652610/ https://www.ncbi.nlm.nih.gov/pubmed/28860128 http://dx.doi.org/10.2337/db16-1478 |
Ejemplares similares
-
4261 Insulin Sensitizing Effects of Vitamin D Mediated through Reduced Adipose Tissue Inflammation and Fibrosis: Evidence from a Human Randomized Trial and Mice Studies
por: Yimagou, Eric Lontchi, et al.
Publicado: (2020) -
Central K(ATP) Channels Modulate Glucose Effectiveness in Humans and Rodents
por: Carey, Michelle, et al.
Publicado: (2020) -
Increased GABAergic Output in the Ventromedial Hypothalamus Contributes to Impaired Hypoglycemic Counterregulation in Diabetic Rats
por: Chan, Owen, et al.
Publicado: (2011) -
Hypoglycemia-Sensing Neurons of the Ventromedial Hypothalamus Require AMPK-Induced Txn2 Expression but Are Dispensable for Physiological Counterregulation
por: Quenneville, Simon, et al.
Publicado: (2020) -
Central Regulation of Glucose Production May Be Impaired in Type 2 Diabetes
por: Esterson, Yonah B., et al.
Publicado: (2016)